Results 141 to 150 of about 1,739 (158)

[Shared Therapeutic Targets of Obesity and Type 2 Diabetes Mellitus and the Intervention Mechanisms of Chinese Herbal Components]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li R, Wang R, Li L, Wang C, Liao T, Zhang B, Yue R.   +6 more
europepmc   +1 more source

[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Lin YY, Liu F, Rao HY.
europepmc   +1 more source

[Recent Advances in the Interorgan Regulatory Roles of Adipose Tissue]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li Z, Xu C, Xu R, Zhou C, Fan Y.
europepmc   +1 more source

[Mechanisms of pyroptosis in metabolic diseases]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Chen R, Wang W.
europepmc   +1 more source

[Study on the correlation between sarcopenia, energy metabolism, and the severity of liver disease in patients with type 2 diabetes mellitus combined with metabolic associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang J, Li Y, Ye Q, Yan NN, Yu HY, Wang FM, Di FS.   +6 more
europepmc   +1 more source

[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Rao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc   +1 more source

[Metabolic Characteristics of Patients With Early-Onset Type 2 Diabetes Mellitus and a Risk Prediction Model for Microvascular Complications]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wang Y, Jiang H, Lyu X, Wang C, Zhao Y, Wei Y, Jing D, Liu J, Zheng L.   +8 more
europepmc   +1 more source

[Meta analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in overweight and obese children and adolescents in China]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Xiao Y, Pan YF, Dai Y, Sun YJ, Zhou Y, Yu YF.   +5 more
europepmc   +1 more source